E-GEOD-46899 - Cyclodextrin protects podocytes in diabetic kidney disease [HumanHT-12 V4.0 array]
Released on 13 July 2013, last updated on 3 June 2014
Analysis of gene expression changes in differentiated human podocytes treated with the serum from patients with (DKD+) or without (DKD-) diabetic kidney disease when compared to normal subjects (C). The hypothesis is that the three groups can be distinghed by their differential gene expression pattern. The results obtained revealed important information regarding differences in gene expression in human podocytes treated with the serum from patients with (DKD+) or without (DKD-) diabetic kidney disease when compared to normal subjects (C). Human podocytes were contacted with the serum from patients with diabetes and kidney disease (DKD+) or without kidney disease (DKD-) and compared to normal human podocytes contacted with serum from patients without diabetes (C).
transcription profiling by array
Sandra Merscher-Gomez <email@example.com>, Alessia Fornoni, Ann Randolph, Armando Mendez, Carol Forsblom, Christopher E Pedigo, Dony Maiguel, George W Burke III, Johanna Guzman, Kevin Johnson, Mariann I Lassenius, Markku Lehto, Matthias Kretzler, Per-Henrik Groop, Robert G Nelson, Robier Aguillon-Prada, Rodrigo Villarreal, Ronald Goldberg, TaeHyun Yoo, Viji Nair